DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry to find novel chemical matter that modulates protein targets of interest. We will discuss how DELopen and DELight kits work. DELopen is a freely accessible collection of DELs that can be used for academic drug-discovery. DELight is a self-service kit that allows pharmaceutical companies to conduct a DEL screen in their own lab, without needing to reveal the identity of their target.

Who should attend

• Academics interested in screening their (protein/biomolecule) targets for drug-like chemical matter using freely accessible DELs.
• Industry scientists interested in conducting DEL screens without revealing target identity and/or developing proprietary screening techniques in their own labs.

What will be learned

• Basics of how the WuXi DEL-encoded library (DEL) platform works
• Workflow and costs for academic labs to access DELopen
• How a pharmaceutical company would use a DELight kit